GLENMEDE TRUST CO NA - DIPLOMAT PHARMACY INC ownership

DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 141 filers reported holding DIPLOMAT PHARMACY INC in Q4 2019. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q1 2020$1,0000.0%4200.0%0.00%
Q4 2019$1,000
-50.0%
4200.0%0.00%
Q3 2019$2,000420
+176.3%
0.00%
Q2 2019$01520.0%0.00%
Q1 2019$0
-100.0%
1520.0%0.00%
Q4 2018$2,0001520.00%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q4 2019
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 445,200$7,101,0001.80%
Redmile Group, LLC 1,254,342$20,007,0001.30%
Irving Magee Investment Management 166,505$2,656,0001.02%
BROADVIEW ADVISORS LLC 376,050$5,998,0000.83%
Sivik Global Healthcare LLC 101,000$1,611,0000.75%
FRONTIER CAPITAL MANAGEMENT CO LLC 5,455,461$87,015,0000.64%
Iguana Healthcare Management, LLC 75,000$1,196,0000.59%
RIVERBRIDGE PARTNERS LLC 1,464,286$23,355,0000.47%
HERMES INVESTMENT MANAGEMENT LTD 1,772,777$28,276,0000.46%
Endurant Capital Management LP 85,043$1,356,0000.44%
View complete list of DIPLOMAT PHARMACY INC shareholders